Sean M. Smith
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Phosphodiesterase function and regulation, Cholinesterase and Neurodegenerative Diseases, Asymmetric Hydrogenation and Catalysis, Receptor Mechanisms and Signaling, Organoboron and organosilicon chemistry
Most-Cited Works
- → The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress(2006)1,863 cited
- → Tau: From research to clinical development(2016)142 cited
- → Efficient Amide-Directed Catalytic Asymmetric Hydroboration(2008)141 cited
- → The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents(2011)139 cited
- → Amide-Directed Catalytic Asymmetric Hydroboration of Trisubstituted Alkenes(2010)125 cited
- → Cocaine- and Amphetamine-Regulated Transcript Activates the Hypothalamic-Pituitary-Adrenal Axis through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism(2004)109 cited